Zepp Health (ZEPP) CTO Meihui Fan Sells 440,000 Shares
ZEPP's CTO, Meihui Fan, sold 440,000 shares on June 26, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Meihui Fan, Chief Technology Officer at Zepp Health Corporation ($ZEPP), sold 440,000 shares on June 26, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $ZEPP is up 21.8% after 1 week, up 8.5% after 1 month and down 32.7% to date (from the $4.49 close on Jun 26, 2026).
ZEPP
Zepp Health Corporation
Key Points
- On June 26, 2026, Meihui Fan, CTO of ZEPP, sold 440,000 shares.
- ZEPP shares traded near $4.73 on Tuesday, with significant institutional interest.
- FIL LTD and Morgan Stanley increased their ZEPP holdings by 14.6% and 16.0%, respectively.
Get $ZEPP trade alerts by text
We text you when insiders, Congress or big funds trade $ZEPP. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Zepp Health Corporation alert may contain errors. Disclosures
Meihui Fan, the Chief Technology Officer of ZEPP, sold 440,000 shares of the company on June 26, 2026. This transaction was not part of a pre-planned trading program. ZEPP shares were trading at approximately $4.73 on Tuesday.
Other Institutional Activity in ZEPP
Several institutional investors made changes to their holdings in ZEPP. FIL LTD increased its stake by 91,596 shares, bringing its total to 717,352 shares valued at about $8.57 million, marking a 14.6% increase. Morgan Stanley also grew its position by 97,397 shares, ending with 707,691 shares worth approximately $8.46 million, reflecting a 16.0% increase. Meanwhile, Point72 Asset Management slightly decreased its holdings by 294 shares, maintaining 577,676 shares valued at around $6.90 million, a minor 0.1% decrease. Millennium Management reduced its position by 24,322 shares, holding 342,504 shares valued at $4.09 million, a 6.6% decrease. Monolith Management added 40,182 shares to its portfolio, now holding 173,847 shares worth $2.08 million, which is a 30.1% increase.
Insider Buying and Selling at Zepp Health Corporation
In addition to Meihui Fan's sale, there were other notable insider transactions at ZEPP. On the same day, Meihui Fan also purchased 520,000 shares. Deng Cheng, the Chief Financial Officer, was active as well, buying 22,875 shares and selling 9,836 shares at $4.61 each. Earlier, on April 1, 2026, Deng Cheng had purchased 366,000 shares.
Analysts Set New Price Targets
Citi maintained its 'buy' rating for ZEPP on August 21, 2023, with a price target of $3.10.
Bottom Line
The recent insider and institutional activities at ZEPP highlight active trading interest in the company. While Meihui Fan's sale of shares is notable, it occurred alongside other significant insider transactions. Institutional investors like FIL LTD and Morgan Stanley have shown confidence by increasing their stakes. As always, remember that these filings reflect past actions and may not indicate current positions.
Related Filing Alerts
Source: Meihui Fan's Form 4 filing on $ZEPP (Jun 26, 2026). Find the original filing: ZEPP Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts